Thymosin alpha-1 activated dendritic cell tryptophan catabolism (IDO pathway), establishing a regulatory immune environment that balances inflammation and tolerance — a sophisticated immune-programming mechanism.
Key findingThymosin alpha-1 activated IDO-mediated tryptophan catabolism in dendritic cells, establishing a regulatory environment with balanced inflammation/tol
What the researchers found
Thymosin alpha-1 activated IDO-mediated tryptophan catabolism in dendritic cells, establishing a regulatory environment with balanced inflammation/tolerance that promotes protective Th1 immunity while maintaining regulatory T-cell suppression — sophisticated immune programming.
Why it matters
Relevant for thymosin-alpha-1, immune-function, infection.
How the study worked
in-vitro study on thymosin-alpha-1, immune-function.
What this study cannot tell us
See abstract.
How to read the evidence
strong evidence.
When this study was published
Published in 2006.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance.
Blood, 108(7), 2265-74
Citation
Romani, Luigina; Bistoni, Francesco; Perruccio, Katia; Montagnoli, Claudia; Gaziano, Roberta; Bozza, Silvia; Bonifazi, Pierluigi; Bistoni, Giovanni; Rasi, Guido; Velardi, Andrea; Fallarino, Francesca; Garaci, Enrico; Puccetti, Paolo. (2006). Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance.. Blood, 108(7), 2265-74.